• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内依赖 I 型干扰素的辅助依赖性腺病毒与腺相关病毒载体的差异型转基因沉默。

Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo.

机构信息

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston,Texas 77030, USA.

出版信息

Mol Ther. 2013 Apr;21(4):796-805. doi: 10.1038/mt.2012.277. Epub 2013 Jan 15.

DOI:10.1038/mt.2012.277
PMID:23319058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3616533/
Abstract

We previously dissected the components of the innate immune response to Helper-dependent adenoviral vectors (HDAds) using genetic models, and demonstrated that multiple pattern recognition receptor signaling pathways contribute to this host response to HDAds in vivo. Based on analysis of cytokine expression profiles, type I interferon (IFN) mRNA is induced in host mouse livers at 1 hour post-injection. This type I IFN signaling amplifies cytokine expression in liver independent of the nature of vector DNA sequences after 3 hours post-injection. This type I IFN signaling in response to HDAds administration contributes to transcriptional silencing of both HDAd prokaryotic and eukaryotic DNA in liver. This silencing occurs early and is mediated by epigenetic modification as shown by in vivo chromatin immunoprecipitation (ChIP) with anti-histone deacetylase (HDAC) and promyelocytic leukemia protein (PML). In contrast, self-complementary adeno-associated viral vectors (scAAVs) showed significantly lower induction of type I IFN mRNA in liver compared to HDAds at both early and late time points. These results show that the type I IFN signaling dependent transgene silencing differs between AAV and HDAd vectors after liver-directed gene transfer.

摘要

我们之前使用遗传模型对 Helper-dependent 腺病毒载体 (HDAd) 的先天免疫反应成分进行了剖析,并证明了多种模式识别受体信号通路有助于宿主对 HDAd 的体内反应。基于细胞因子表达谱的分析,在注射后 1 小时,宿主小鼠肝脏中诱导产生 I 型干扰素 (IFN) mRNA。这种 I 型 IFN 信号在注射后 3 小时后独立于载体 DNA 序列的性质在肝脏中放大细胞因子的表达。这种对 HDAd 给药的 I 型 IFN 信号反应导致肝脏中 HDAd 原核和真核 DNA 的转录沉默。这种沉默发生得很早,并且如体内染色质免疫沉淀 (ChIP) 所示,通过抗组蛋白去乙酰化酶 (HDAC) 和早幼粒细胞白血病蛋白 (PML) 的表观遗传修饰介导。相比之下,与 HDAd 相比,自互补腺相关病毒载体 (scAAV) 在早期和晚期时间点在肝脏中诱导 I 型 IFN mRNA 的表达明显降低。这些结果表明,在肝脏定向基因转移后,AAV 和 HDAd 载体之间的 I 型 IFN 信号依赖性转基因沉默存在差异。

相似文献

1
Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo.体内依赖 I 型干扰素的辅助依赖性腺病毒与腺相关病毒载体的差异型转基因沉默。
Mol Ther. 2013 Apr;21(4):796-805. doi: 10.1038/mt.2012.277. Epub 2013 Jan 15.
2
MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus.MyD88 依赖性沉默物在辅助依赖性腺病毒先天和适应性免疫反应中转基因表达。
Hum Gene Ther. 2010 Mar;21(3):325-36. doi: 10.1089/hum.2009.155.
3
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.NOD2 信号通路有助于先天免疫反应对抗辅助依赖性腺病毒载体,而不依赖于体内的 MyD88。
Hum Gene Ther. 2011 Sep;22(9):1071-82. doi: 10.1089/hum.2011.002. Epub 2011 Jul 8.
4
Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression.宿主细胞对辅助依赖型腺病毒载体中所含非编码填充DNA的检测会导致转基因表达的表观遗传抑制。
J Virol. 2009 Sep;83(17):8409-17. doi: 10.1128/JVI.00796-09. Epub 2009 Jun 10.
5
The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver.小鼠肝脏对腺病毒、辅助依赖型腺病毒和腺相关病毒的宿主反应。
Mol Ther. 2008 May;16(5):931-41. doi: 10.1038/mt.2008.37. Epub 2008 Mar 18.
6
Helper-dependent adenoviral vectors for liver-directed gene therapy.辅助依赖性腺病毒载体用于肝脏定向基因治疗。
Hum Mol Genet. 2011 Apr 15;20(R1):R7-13. doi: 10.1093/hmg/ddr143. Epub 2011 Apr 5.
7
Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.使用不同血清型的辅助依赖型腺病毒载体可允许重复给予载体。
Gene Ther. 1999 Sep;6(9):1565-73. doi: 10.1038/sj.gt.3300995.
8
Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges.肝靶向基因治疗辅助依赖性腺病毒载体:现状与未来挑战。
Curr Pharm Des. 2011;17(24):2488-99. doi: 10.2174/138161211797247532.
9
Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.用辅助依赖型腺病毒载体进行基因治疗:大型动物模型研究的经验教训。
Virus Genes. 2017 Oct;53(5):684-691. doi: 10.1007/s11262-017-1471-x. Epub 2017 Jun 7.
10
Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors.辅助依赖性腺病毒载体肝转导后非人类灵长类动物中转基因表达长达 7 年。
Hum Gene Ther. 2013 Aug;24(8):761-5. doi: 10.1089/hum.2013.071.

引用本文的文献

1
Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient.向非人灵长类动物肌肉内注射腺相关病毒(AAV)后,免疫驱动的基因表达缺失只是短暂的。
Mol Ther Methods Clin Dev. 2025 Jan 19;33(1):101409. doi: 10.1016/j.omtm.2025.101409. eCollection 2025 Mar 13.
2
Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity.在经临床测试的溶瘤腺免疫疗法中,T细胞衔接器的额外表达可将肿瘤浸润的无关T细胞重定向至癌细胞,以增强抗肿瘤免疫力。
J Immunother Cancer. 2024 Dec 9;12(12):e009741. doi: 10.1136/jitc-2024-009741.
3
Innate Immune Sensing of Adeno-Associated Virus Vectors.腺相关病毒载体的先天免疫感应。
Hum Gene Ther. 2024 Jul;35(13-14):451-463. doi: 10.1089/hum.2024.040. Epub 2024 Jul 5.
4
Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy.工程化溶瘤腺病毒:一种新兴的癌症治疗方法。
Pathogens. 2022 Oct 4;11(10):1146. doi: 10.3390/pathogens11101146.
5
HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy.HydrAd:一种靶向多种免疫途径用于癌症免疫治疗的辅助依赖型腺病毒。
Cancers (Basel). 2022 Jun 2;14(11):2769. doi: 10.3390/cancers14112769.
6
Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the Hedgehog.腺相关病毒(AAV)和宿主免疫 - 野兔和刺猬之间的竞赛。
Front Immunol. 2021 Oct 29;12:753467. doi: 10.3389/fimmu.2021.753467. eCollection 2021.
7
Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors.溶瘤腺病毒免疫疗法调节免疫系统,使 CAR T 细胞能够治愈胰腺肿瘤。
Commun Biol. 2021 Mar 19;4(1):368. doi: 10.1038/s42003-021-01914-8.
8
Safety profile of the transcription factor EB (TFEB)-based gene therapy through intracranial injection in mice.通过颅内注射在小鼠中进行基于转录因子EB(TFEB)的基因治疗的安全性概况。
Transl Neurosci. 2020 Jul 15;11(1):241-250. doi: 10.1515/tnsci-2020-0132. eCollection 2020.
9
Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors.溶瘤腺病毒武装双特异性 T 细胞结合分子、细胞因子和检查点抑制剂使 CAR T 细胞能够控制异质性肿瘤的生长。
Mol Ther. 2020 May 6;28(5):1251-1262. doi: 10.1016/j.ymthe.2020.02.016. Epub 2020 Feb 24.
10
Immune Responses to Viral Gene Therapy Vectors.病毒基因治疗载体的免疫反应。
Mol Ther. 2020 Mar 4;28(3):709-722. doi: 10.1016/j.ymthe.2020.01.001. Epub 2020 Jan 10.

本文引用的文献

1
Coagulation factor X activates innate immunity to human species C adenovirus.凝血因子 X 激活人体 C 型腺病毒固有免疫。
Science. 2012 Nov 9;338(6108):795-8. doi: 10.1126/science.1226625. Epub 2012 Sep 27.
2
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.腺相关病毒载体介导的乙型血友病基因转移。
N Engl J Med. 2011 Dec 22;365(25):2357-65. doi: 10.1056/NEJMoa1108046. Epub 2011 Dec 10.
3
Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors.Toll 样受体 2 介导的人非实质肝细胞对腺相关病毒载体的固有免疫反应。
Hepatology. 2012 Jan;55(1):287-97. doi: 10.1002/hep.24625.
4
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.NOD2 信号通路有助于先天免疫反应对抗辅助依赖性腺病毒载体,而不依赖于体内的 MyD88。
Hum Gene Ther. 2011 Sep;22(9):1071-82. doi: 10.1089/hum.2011.002. Epub 2011 Jul 8.
5
Immune responses to AAV in clinical trials.临床试验中对 AAV 的免疫反应。
Curr Gene Ther. 2011 Aug;11(4):321-30. doi: 10.2174/156652311796150354.
6
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges.利用 AAV 进行体内基因治疗遗传性疾病:进展与挑战。
Nat Rev Genet. 2011 May;12(5):341-55. doi: 10.1038/nrg2988.
7
The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver.自互补型腺相关病毒载体的基因组可增强肝脏中 Toll 样受体 9 依赖性固有免疫应答。
Blood. 2011 Jun 16;117(24):6459-68. doi: 10.1182/blood-2010-10-314518. Epub 2011 Apr 7.
8
Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy.腺相关病毒 (AAV) 载体激活 NF-κB 通路及其在免疫反应和基因治疗中的意义。
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3743-8. doi: 10.1073/pnas.1012753108. Epub 2011 Feb 14.
9
Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus.聚乙二醇化辅助依赖性腺病毒的药理学和毒理学的种属差异。
Mol Pharm. 2011 Feb 7;8(1):78-92. doi: 10.1021/mp100216h. Epub 2010 Sep 23.
10
MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus.MyD88 依赖性沉默物在辅助依赖性腺病毒先天和适应性免疫反应中转基因表达。
Hum Gene Ther. 2010 Mar;21(3):325-36. doi: 10.1089/hum.2009.155.